本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

HealthEquity

94.04
+0.81000.87%
盘前94.400.3600+0.38%09:04 EDT
成交量:83.58万
成交额:7,890.34万
市值:81.02亿
市盈率:57.12
高:95.67
开:93.21
低:92.70
收:93.23
52周最高:116.65
52周最低:74.07
股本:8,615.63万
流通股本:8,486.15万
量比:1.07
换手率:0.98%
股息:- -
股息率:- -
每股收益(TTM):1.65
每股收益(LYR):1.11
净资产收益率:6.78%
总资产收益率:4.93%
市净率:3.77
市盈率(LYR):84.48

数据加载中...

2025/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/06/03

重要事件披露

Form 8-K - Current report
2025/04/28

重要事件披露

Form 8-K - Current report
2025/04/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/18

重要事件披露

Form 8-K - Current report
2025/02/19

重要事件披露

Form 8-K - Current report
2025/02/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities